Introduction {#section1-2058738419855873}
============

Cleft of the lip with or without cleft palate (CL/P) is the most common orofacial malformation, with a prevalence close to 1/1000 at birth.^[@bibr1-2058738419855873]^ However, the prevalence varies depending on ethnic origin.^[@bibr2-2058738419855873],[@bibr3-2058738419855873]^ The non-syndromic cleft lip with or without cleft palate (nsCL/P) is a heterogeneous disorder with multiple phenotypic presentations and is considered a typical example of trait with complex inheritance, where a combination of multiple genetic and environmental factors contributes to phenotype expression. Twin studies are commonly used to investigate etiology of common diseases with complex inheritance. Monozygotic (MZ) or identical twins result from a single ovum, fertilized by one sperm, while dizygotic (DZ) twins result from two different ova, fertilized by two different sperm. Otherwise from DZ twins, which originate from two zygotes and share on average half of the genome, MZ twins are long thought to share 100% of their genomic information, because they originate from the same zygote. However, additional genetic components, such as epigenetic factors and postzygotic somatic mutation events, may explain different traits of expression in MZ twins.^[@bibr4-2058738419855873],[@bibr5-2058738419855873]^ Increasing evidences of genetic differences have been reported both in typically developing and in clinically discordant MZ pairs.^[@bibr6-2058738419855873]^

Twin studies demonstrated a consistent genetic component in nsCL/P etiology, indeed a higher concordance rate in MZ (25%--50%) was often observed compared to DZ (3%--6%) twins.^[@bibr7-2058738419855873]^ Molecular analysis of discordant MZ twins has been attempted to identify nsCL/P genetic factors. A de novo nonsense mutation in *IRF6* was detected in the affected twin of a twin pair discordant for the presentation of Van der Woude clefting syndrome.^[@bibr8-2058738419855873]^ However, other investigations, using different technical approaches, were unsuccessful to identify genetic differences in discordant nsCL/P twin pairs.^[@bibr9-2058738419855873][@bibr10-2058738419855873][@bibr11-2058738419855873]--[@bibr12-2058738419855873]^

Discordant MZ twin pairs, that are informative in respect to variability of phenotypic expression, epigenetics, and postzygotic mutagenesis, may represent an alternative approach to identify genes in inherited disorders. We hypothesized that postzygotic de novo mutations could cause discordant MZ twin pairs for nsCL/P, that are otherwise genetically identical. To test this hypothesis we have investigated two MZ twin pairs by means of high-density SNP genotyping arrays that consent the analysis of postzygotic de novo copy number variation (CNV) events.

Materials and methods {#section2-2058738419855873}
=====================

Discordant twin pair collection was part of a broader investigation aimed to identify inherited susceptibility factors of nsCL/P.^[@bibr13-2058738419855873]^ A team of clinicians performed the diagnosis and excluded additional birth malformations or metabolic diseases. A detailed interview excluded families that may be subjected to known or suspected clefting agents, such as phenytoin, warfarin, ethanol, and smoking. The study was approved by the local ethics committees and it complied with the Helsinki Declaration's Ethical Principles for Medical Research Involving Human Subjects. Written informed consent was obtained from all patients and parents.

Five twin pairs discordant for nsCL/P were identified. Genomic DNA was extracted and purified from whole blood using standard techniques. Twin pairs were analyzed for zigosity by direct genotype comparison of a panel of highly polymorphic microsatellite DNA loci. Three twin pairs were excluded from the investigation because the originated by different zygotes. Two molecularly ascertained MZ twin pairs that were discordant for nsCL/P were analyzed by high-density SNP microarray. Genotyping was performed using the Illumina HumanOmni1-Quad array, which contains nearly 1.14 million markers including SNP and CNV probes.

BeadChip data were processed using GenomeStudioV2011.1 (Illumina Inc.) and PennCNV.^[@bibr14-2058738419855873]^ Primary data analyses, including raw data normalization, clustering, and genotype calling were performed using algorithms in the genotyping module. The software derives, for each sample, log R ratios (LRRs) and B allele frequencies for each probe on the Quad array; the LRR reflects relative probe fluorescence intensity, which varies with the discrete number of copies of probe-specific DNA present within an individual's genome. A copy number state of 2 per individual is considered normal (one copy per chromosome); lower value reflects copy number loss and higher values, a copy number gain. Each sample CNV pool was subjected to filtering steps in order to remove alteration smaller than 10 kb in size and containing lower than 5 probes. CNV that passed these filtering steps were retained for downstream analysis. Chromosome regions annotations were obtained from UCSC Refseq track Human genome build 19. All analyses were conducted with R version 3.4.3, Platform: x86 64-pc-linux-gnu (64-bit) running under Ubuntu 16.04.3 LTS.

Results {#section3-2058738419855873}
=======

Genotyping of SNPs of the four DNA samples by microarray hybridization produced high quality results; indeed, for each sample, the genotype call rate was \>99.7%. As expected, the comparison of genotypes between the affected and the unaffected twin revealed a high level of concordance in each twin pair ([Table 1](#table1-2058738419855873){ref-type="table"}). Indeed, only 25 (0.002% of total genotypes) discordant calls were observed in each pair. The high level of concordance confirmed that twin pairs were actually MZ, while discordant SNP genotypes could be explained as either genotyping errors or de novo mutations. Discordant polymorphisms did not alter gene coding sequences, and they were not classified as pathogenic in the ClinVar database.

###### 

Comparison of SNP genotypes between the discordant twins.

![](10.1177_2058738419855873-table1)

  Twin pair   Sample ID       \# concordant SNPs   \# discordant SNPs
  ----------- --------------- -------------------- --------------------
  1           NBF3-NBF4       1,011,267            25
  2           100101-100104   1,011,764            25

The intensities of allele probe hybridization in the SNP array platforms were analyzed to evaluate the ploidy of each tested locus. Indeed, CNVs such as duplication and deletion increase or decrease the total measured intensities; moreover, for large CNVs that span multiple SNPs, intensity ratios have patterns distinct from normal disomic genomic regions. In this investigation, we considered CNV regions spanning more than 10 kbp. In the four samples, the number of detected CNVs varied between 51 and 70 with a median length of 23 kbp. In order to identify inherited CNVs that could act as nsCL/P susceptibility loci, we first looked for CNVs detected in all the investigated samples ([Table 2](#table2-2058738419855873){ref-type="table"}). Two CNVs of the list consisted of deletions that did not include any transcripted sequence. The remaining CNVs spanned 12 genes, including *JAG2* a possible genetic factor of nsCL/P.

###### 

List of CNVs detected in all analyzed samples.

![](10.1177_2058738419855873-table2)

  Chr.   Start         End           Width     \# of SNPs   CNV_TYPE   Genes
  ------ ------------- ------------- --------- ------------ ---------- -------------------------------------------------------------------
  2      41,092,961    41,103,770    10,810    13           Loss       −
  2      88,932,848    89,090,893    15,8046   59           Gain       *RPIA, ANKRD36BP2*
  6      103,850,891   103,868,723   17,833    9            Deletion   −
  8      32,799,628    32,810,651    11,024    14           Deletion   −
  11     55,122,337    55,175,539    53,203    35           Loss       *OR4A15*
  14     105,275,606   105,697,201   421,596   244          Gain       *JAG2, CEP170B, PLD4, AHNAK2, CDCA4, GPR132, NUDT14, BRF1, BTBD6*

CNV: copy number variation.

Then we focused on genetic differences in each twin pair, particularly to CNVs that may account for phenotype discordance. The CNVs detected exclusively in the affected individual of each pair are shown in [Table 3](#table3-2058738419855873){ref-type="table"}. Such CNVs include 34 out of 66 variations detected in patient ID = 100101, and 13 out of 50 variations detected in patient ID = NBF3.

###### 

List of CNVs that were detected only in the CL/P affected twin.

![](10.1177_2058738419855873-table3)

  Patient ID   Chr.   Start         End           Width     \# of SNPs   CNV type   Genes involved
  ------------ ------ ------------- ------------- --------- ------------ ---------- -------------------------------
  100101       2      14,109,052    14,119,079    10,028    10           Loss       −
  100101       2      52,607,219    52,621,681    14,463    5            Loss       −
  100101       2      89,904,056    89,920,851    16,796    10           Gain       
  100101       2      97,150,351    97,165,854    15,504    6            Loss       *NEURL3*
  100101       2      153,489,894   153,508,850   18,957    22           Loss       *FMNL2, PRPF40A*
  100101       2      238,262,529   238,275,105   12,577    15           Gain       *COL6A3*
  100101       3      149,649,355   149,660,146   10,792    5            Loss       *RNF13*
  100101       4      14,529,946    14,543,205    13,260    12           Loss       −
  100101       4      100,728,344   100,744,538   16,195    11           Loss       *DAPP1*
  100101       4      144,879,245   144,889,446   10,202    9            Loss       −
  100101       5      18,365,795    18,382,021    16,227    14           Loss       −
  100101       5      84,822,505    84,868,110    45,606    8            Loss       −
  100101       6      29,962,774    29,981,888    19,115    78           Gain       *HLAH, HLAG, HLAJ*
  100101       6      67,893,398    67,923,322    29,925    13           Loss       −
  100101       6      67,954,304    68,004,709    50,406    19           Loss       −
  100101       6      77,496,688    77,509,808    13,121    22           Loss       −
  100101       6      141,015,260   141,045,617   30,358    8            Loss       −
  100101       7      142,157,556   142,172,768   15,213    13           Loss       *TCRBV22S1A2N1T, TCRBV5S1A1T*
  100101       8      130,571,112   130,581,329   10,218    10           Loss       *--*
  100101       9      10,384,286    10,395,076    10,791    11           Deletion   *PTPRD*
  100101       11     48,284,271    48,304,374    20,104    36           Loss       *OR4X1*
  100101       11     51,052,130    51,152,453    100,324   8            Gain       *--*
  100101       11     114,007,895   114,017,913   10,019    10           Loss       *ZBTB16*
  100101       12     74,069,809    74,089,055    19,247    10           Loss       −
  100101       13     17,982,800    18,006,081    23,282    7            Gain       −
  100101       13     71,012,389    71,028,770    16,382    8            Loss       −
  100101       14     79,168,636    79,184,616    15,981    17           Loss       *NRXN3*
  100101       15     19,129,051    19,158,166    29,116    14           Loss       −
  100101       17     31,478,254    31,501,499    23,246    22           Gain       *ASIC2*
  100101       17     41,004,182    41,016,180    11,999    16           Gain       *AOC3*
  100101       18     62,342,876    62,353,618    10,743    5            Loss       −
  100101       18     64,098,920    64,110,327    11,408    16           Loss       −
  100101       20     1,524,714     1,537,988     13,275    8            Gain       *SIRPD*
  100101       22     22,697,511    22,725,367    27,857    13           Gain       *abParts*
  NBF3         2      34,809,903    34,820,073    10,171    15           Loss       −
  NBF3         2      91,293,640    91,322,549    28,910    12           Loss       −
  NBF3         3      198,837,449   198,871,090   33,642    13           Loss       −
  NBF3         6      26,849,823    26,860,992    11,170    15           Loss       −
  NBF3         6      32,617,395    32,633,666    16,272    24           Gain       *HLA-DQB1*
  NBF3         7      57,728,536    57,767,235    38,700    13           Gain       *GUSBP2*
  NBF3         7      64,895,813    64,925,393    29,581    15           Gain       −
  NBF3         10     46,781,951    46,805,985    24,035    7            Gain       *PTPN20, GLUD1P7*
  NBF3         14     105,648,434   105,725,651   77,218    9            Gain       *BRF1, BTBD6*
  NBF3         16     34,343,935    34,601,761    257,827   27           Gain       *LINC01566, UBE2MP1*
  NBF3         16     68,615,369    68,650,243    34,875    6            Gain       −
  NBF3         18     14,211,931    14,239,072    27,142    6            Gain       *ANKRD20A5P*
  NBF3         20     1,526,976     1,541,888     14,913    9            Gain       *SIRPD*

CNV: copy number variation.

No overlap between the two CNV lists, specific for each twin pair, was found.

Discussion {#section4-2058738419855873}
==========

Several factors could contribute to discordance of diseases between MZ twins, including postzygotic somatic mutations, X chromosome inactivation, differential methylation, stochastic factors, and non-genetic intrauterine environmental factors such as unequal cell allocation at twinning and disproportionate placental blood supply.^[@bibr5-2058738419855873],[@bibr15-2058738419855873]^ Discordant MZ twins can be a valuable resource for complex diseases, indeed genetic comparison of discordant twins could potentially help to increase reliability of candidate genes in complex diseases or to find novel disease susceptibility genes that could partly explain missing heritability.

The current study reports genome-wide SNP and CNV results on two MZ twin pairs discordant for nsCL/P. A small number of in-pair discordant SNP genotypes were found; none of them appeared as a probable causative mutation. The genotype discrepancy may be related to genotyping inaccuracy of large-scale microarray typing, although at a level similar to those previously reported.^[@bibr11-2058738419855873]^ We searched for postzygotic CNVs that may account for the discordant phenotype. In addition, we analyzed the shared CNVs among twin pairs looking for variants of face development genes. Lists of selected CNVs were reported along with annotations including involved genes and previous contribution to clinical relevant data. The reported genetic regions and genes did not overlap with any of the candidate regions by previous genome wide allelic association analyses. These data partially agree with a previous report by Shi et al. who investigated 333 nsCL/P candidate genes for CNVs; they found that CNVs could have a role in nsCL/P etiology but with relatively rare occurrence. Indeed, analyzing 725 nsCL/P Scandinavian families, they identified only seven deletions.^[@bibr16-2058738419855873]^

Previous investigations attempted the identification of nsCL/P genetic factors by comparison of discordant MZ twins. Mansilla et al.,^[@bibr9-2058738419855873]^ by comparing sequences of 18 candidate genes, did not find etiologic somatic mutations in 13 MZ pairs. Similarly, Kimani et al.^[@bibr10-2058738419855873]^ investigated 25 discordant MZ twin pairs with different genome scale genetic methods; they not only concluded that postzygotic genomic alterations are not a common cause of MZ twin discordance for isolated nsCL/P but also suggested that detection of discordant events in other MZ twin pairs would be remarkable and of potential disease significance.

A possible limitation of our study was related with the CNV calling method from microarray data. Indeed, discrimination of biologically relevant data from noise CNV is still a bioinformatics challenge and different algorithms produce different results.^[@bibr17-2058738419855873]^ We tried to increase accuracy for CNV calling by setting stringent threshold of CNV size and spanning SNP number. However, this could reduce sensitivity increasing missing calls, while the false positive call remains a concrete possibility, as observed in other investigations.^[@bibr18-2058738419855873]^ There is no clear estimate of the rate of somatic CNVs, and our sample that is limited to discordant twins, in theory should have a higher rate of such events. Considering all these limitations, together with the small size of our sample study, the results of this investigation should be considered with caution and more data obtained with different technical approaches are needed to evaluate the real impact of CNVs in nsCL/P. Further investigations of specifically involved tissue, aimed to screen for epigenetic factors or postzygotic somatic mutation events, could possibly help to explain different trait expression in MZ twins.
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